Navigation Links
BNY Mellon Appointed as Depositary by Mazor Robotics Ltd.
Date:6/10/2013

NEW YORK, June 10, 2013 /PRNewswire/ -- BNY Mellon, the global leader in investment management and investment services, has been appointed by Mazor Robotics Ltd. as depositary bank for its American depositary receipt (ADR) program. Each Mazor Robotics ADR represents two ordinary shares and trades on NASDAQ under the symbol "MZOR." Mazor Robotics' ordinary shares trade on the Tel Aviv Stock Exchange under the symbol "MZOR."

Mazor Robotics develops innovative surgical guidance systems and complementary products in the spinal surgery market that have been used in more than 35,000 implants in the U.S., Asia and Europe. Its flagship product, Renaissance™, is a state-of-the-art system that enables surgeons to conduct spinal surgeries accurately. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability and clinical advantages of Mazor Robotics' technology.

"The momentum created by the successful market penetration of our Renaissance systems, coupled with the availability of our ADRs on NASDAQ, means U.S. investors will be able to share in our continued progress," commented Ori Hadomi, Mazor Robotics' president and CEO.

"Mazor's decision shows yet another Israeli company understanding the many benefits of DRs both for issuing companies and their investors abroad," said Christopher M. Kearns, CEO of BNY Mellon's Depositary Receipts business. "We believe their listing in the U.S. has the potential to widen Mazor's investor base dramatically."

BNY Mellon acts as depositary for more than 2,700 American and global depositary receipt programs, acting in partnership with leading companies from 68 countries. BNY Mellon is committed to helping securities issuers access the world's rapidly evolving financial markets and delivers a comprehensive suite of depositary receipt services. Learn more at www.bnymellon.com/dr

BNY Mellon is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle. Whether providing financial services for institutions, corporations or individual investors, BNY Mellon delivers informed investment management and investment services in 36 countries and more than 100 markets. As of March 31, 2013, BNY Mellon had $26.3 trillion in assets under custody and/or administration, and $1.4 trillion in assets under management. BNY Mellon can act as a single point of contact for clients looking to create trade, hold, manage, service, distribute or restructure investments. BNY Mellon is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK). Learn more at bnymellon.com, or follow us on Twitter @BNYMellon

This release is for informational purposes only. BNY Mellon provides no advice nor recommendation or endorsement with respect to any company or securities. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities. Depositary Receipts: Not FDIC, State or Federal Agency Insured; May Lose Value; No Bank, State or Federal Agency Guarantee.


'/>"/>
SOURCE BNY Mellon
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Carnegie Mellons Christopher Bettinger Develops Edible Electronics for Medical Device Industry
2. Carnegie Mellon University Biomedical Engineers Lead Collaborative Team Developing New Astro Surgery Tools for NASA Deep Space Missions
3. Parents Less Likely To Develop Colds, Carnegie Mellon Research Shows
4. Rethinking Research Ethics: Carnegie Mellon and McGill Researchers Challenge Post-marketing Trial Practices
5. Randy Hill Appointed to Vasomedical Board of Directors
6. Lynn Kramer, MD, Appointed Chief Clinical Officer of Eisai Product Creation Systems
7. Ken Mulvany Appointed Chairman of The Cure Parkinsons Trust
8. David Norton Appointed to TB Alliances Board of Directors
9. Searcy Denney Scarola Barnhart & Shipley Attorney Appointed to Plaintiffs Steering Committee for Stryker Hip Implant Litigation
10. Graham Cooper Appointed Chief Financial Officer of Receptos
11. Gregory D. Cash Appointed President and Chief Executive Officer of NeuroTherm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Allergy Diagnostics Market: Scope and Methodology ... are used to determine the presence of allergens ... etc. in the samples by determining the presence ... report on global allergy diagnostics market, analyzes the ... report consists of an executive summary that provides ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced the addition ... their offering. ... This report analyzes the worldwide markets for Endodontic Supplies in US$ ... , Japan , Europe , ... World. Annual estimates and forecasts are provided for the period 2015 ...
(Date:12/8/2016)... de 2016  A Mederi Therapeutics Inc . anunciou aprovação regulatória, pela ... para a doença do refluxo gastroesofágico (DRGE). Foto -  http://photos.prnewswire.com/prnh/20161207/446903 ... ... Live Stretta procedure performed and broadcast during the Chinese Congress of ... , , ...
Breaking Medicine Technology:
(Date:12/10/2016)... ... December 10, 2016 , ... When faced with having to use ... from the seat to her body, and contamination of children when they use public ... solve this problem that many people face. , The patent-pending SANI-POCKET enables a person ...
(Date:12/9/2016)... ... , ... "I have gout, and I wanted to treat it naturally," said ... to relieve gout and pain caused by varicose veins. I drank it every morning ... relieved what VA doctors called the worst sinusitis case they'd seen and relieved gas, ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... The Pierre Hotel in New York, NY, on December 3rd, to benefit Holy ... physicians attended the annual event, which raised over $1 million - the largest ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Florida Hospital ... and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. This accreditation ... a few hospitals and facilities have earned this distinction. This is the second ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
Breaking Medicine News(10 mins):